Items where authors include "Delforge, M"

Article

Ludwig, H L, Terpos, E, van de Donk, N et al. (26 more authors) (2023) Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network. The Lancet Oncology, 24 (6). e255-e269. ISSN 1470-2045

Dimopoulos, MA, Moreau, P, Terpos, E et al. (14 more authors) (2022) Corrigendum to “Corrigendum to ‘Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up’”: [Ann Oncol Volume 33, Issue 1, January 2022, Page 117]. Annals of Oncology, 33 (9). p. 988. ISSN 0923-7534

Dimopoulos, MA, Moreau, P, Terpos, E et al. (15 more authors) (2022) Corrigendum to ‘Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up’: [Ann Oncol 2021; 32(3): 309-322]. Annals of Oncology, 33 (1). p. 117. ISSN 0923-7534

Ludwig, H, Sonneveld, P, Facon, T et al. (33 more authors) (2021) COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network. The Lancet Haematology, 8 (12). e934-e946. ISSN 2352-3026

Weisel, K, Mateos, M-V, Gay, F et al. (6 more authors) (2021) Efficacy and safety profile of deep responders to carfilzomib-based therapy: a subgroup analysis from ASPIRE and ENDEAVOR. Leukemia, 35 (6). pp. 1732-1744. ISSN 0887-6924

Dimopoulos, MA, Moreau, P, Terpos, E et al. (14 more authors) (2021) Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up. HemaSphere, 5 (2). e528. ISSN 2572-9241

Moreau, P, Sonneveld, P, Boccadoro, M et al. (13 more authors) (2019) Chimeric Antigen Receptor T-Cell Therapy For Multiple Myeloma: A Consensus Statement From The European Myeloma Network. Haematologica, 104 (12). pp. 2358-2360. ISSN 0390-6078

Ludwig, H, Delforge, M, Facon, T et al. (29 more authors) (2018) Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network. Leukemia, 32 (7). pp. 1542-1560. ISSN 0887-6924

Moreau, P, van de Donk, NWCJ, San Miguel, J et al. (17 more authors) (2016) Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma (vol 76, pg 853, 2016). Drugs, 76 (9). pp. 989-990. ISSN 0012-6667

Proceedings Paper

Weisel, K, Mateos, M-V, Gay, FM et al. (6 more authors) (2018) Association between Patient Profile and Outcomes of Best Responders to Carfilzomib: A Post-Hoc Sub-Group Analysis of Aspire and Endeavor. In: Blood. ASH 2018 – 60th American Society of Hematology Annual Meeting and Exposition, 01-04 Dec 2018, San Diego, CA. American Society of Hematology , p. 3299.